About
Evan Floden is the CEO and co-founder of Seqera, a company that develops and supports Nextflow, a workflow engine for scalable and reproducible data analysis. His background spans biomedicine, bioinformatics, and biotechnology, including work on a bioscaffold platform for tissue regeneration at Aroa Biosurgery and contributions to the Rfam and Pfam databases at the Sanger Institute.
Founder at Seqera
Intro paths
→
In turn, Evan can intro founders to Seqera's investors below.
Seqera's investors · 2
Experience
- SeqeraCEO & Co-foundercurrent2018 — presentBarcelona Area, Spain
- Centre for Genomic Regulation (CRG)Postdoctoral Researcher2018 — 2020Barcelona Area, Spain
- Wellcome Trust Sanger InstituteSenior Bioinformatician2014Cambridge, United Kingdom
- Aroa Biosurgery LimitedDevelopment Scientist2008 — 2012
- Victoria University of WellingtonResearch Assistant2006 — 2008
Skills & more
Perl3Python8R5Github1LinuxHTMLPHPSQLStartupsNextflowEntrepreneurshipBioinformatics7
+10 more
Algorithm ImplementationBiological Database DevelopmentNGS Data AnalysisGeneticsCell CultureDynamic Web DesignPCRComputational BiologyBiochemistryPolymerase Chain Reaction (PCR)Languages English · Italian · Spanish
From Evan's professional profile.
Frequently asked questions
- Who is Evan Floden?
- Evan Floden is the CEO and co-founder of Seqera, a company that develops and supports Nextflow, a workflow engine for scalable and reproducible data analysis. His background spans biomedicine, bioinformatics, and biotechnology, including work on a bioscaffold platform for tissue regeneration at Aroa Biosurgery and contributions to the Rfam and Pfam databases at the Sanger Institute.
- Where does Evan Floden work?
- Evan Floden is Founder of Seqera.
- What companies did Evan Floden found?
- Evan Floden founded Seqera.
- Where did Evan Floden go to school?
- Evan Floden studied at Universitat Pompeu Fabra (Doctor of Philosophy - PhD, Biomedicine); Alma Mater Studiorum – Università di Bologna (International Masters in Bioinformatics, Biomathematics); Victoria University of Wellington (BSc, Biotechnology).
Same school
Also attended Universitat Pompeu Fabra112
David GraingerInvestor at MedicxiAniol BrosaGeneral Partner at Inveready Technology Investment GroupErnest GassóDirector at Inveready Technology Investment GroupIgnacio PuigGeneral Partner at Inveready Technology Investment GroupLaia PratsHead of Legal & ESG at Inveready Technology Investment GroupJake MedwellInvestment Team at 8VC
+ 106 more
Also attended Alma Mater Studiorum – Università di Bologna85
Edoardo MingozziPortfolio Support Analyst at P101 VenturesClare McCartney BeerCOO & Managing Director at Burda Principal InvestmentsIrene MingozziVenture Partner at E12 Venture Capital, LlcLuca BarbiGeneral Partner & COO at STVMariana RomeroSenior Associate at NazcaHannah ArrighiVice President at Center15 Capital
+ 79 more
Also attended Victoria University of Wellington91
Helen SounessVenture Partner at RampersandDerek HandleyFuturist, entrepreneur, and student fascinated by what it means to live well in an increasingly chaotic worldIsabel VerheggenGlobal Head of Marketing, CV Labs at CV LabsRachel HindPrivate Client Adviser at Aura GroupCarolynChief Credit Officer at Terra Firma Capital CorporationKarin LouženskáCOO at Rockaway Ventures
+ 85 more
Also attended Whanganui Collegiate School1
.png)
Shared employers
Also worked at Seqera5
Also worked at Centre for Genomic Regulation (CRG)6
Malgorzata RogalskaAssociate at Ysios CapitalJamie RapperportGeneral Partner at J4 VenturesPablo CironiManaging Director at Criteria Bio VenturesSalvatore CappadonaSenior Associate at Criteria Bio VenturesGabrielle BertierSenior Analyst at Finchley Healthcare VenturesDr. Maria Chatzou DunfordFounder at Lifebit Biotech
